Data as of Dec 06
| +0.30 / +0.74%|
The 12 analysts offering 12-month price forecasts for Mindray Medical International Ltd have a median target of 41.00, with a high estimate of 50.00 and a low estimate of 27.00. The median estimate represents a +0.86% increase from the last price of 40.65.
The current consensus among 13 polled investment analysts is to Buy stock in Mindray Medical International Ltd. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.